Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective

The association of opportunistic infections in the context of anti-tumor necrosis factor (TNF) antibody therapies have attracted widespread attention. The recent H1N1 influenza pandemic brought this into sharp focus with numerous patient queries and physician anxieties. The following short review gi...

Full description

Bibliographic Details
Main Authors: Matt Shale, Markus Czub, Gilaad G. Kaplan, Remo Panaccione, Subrata Ghosh
Format: Article
Language:English
Published: SAGE Publishing 2010-05-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/1756283X10366368
_version_ 1818035628903759872
author Matt Shale
Markus Czub
Gilaad G. Kaplan
Remo Panaccione
Subrata Ghosh
author_facet Matt Shale
Markus Czub
Gilaad G. Kaplan
Remo Panaccione
Subrata Ghosh
author_sort Matt Shale
collection DOAJ
description The association of opportunistic infections in the context of anti-tumor necrosis factor (TNF) antibody therapies have attracted widespread attention. The recent H1N1 influenza pandemic brought this into sharp focus with numerous patient queries and physician anxieties. The following short review gives a scientific perspective to this issue including the role of vaccination.
first_indexed 2024-12-10T06:58:05Z
format Article
id doaj.art-b54597ac4251433e86ef4ad2d249e4a6
institution Directory Open Access Journal
issn 1756-283X
language English
last_indexed 2024-12-10T06:58:05Z
publishDate 2010-05-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Gastroenterology
spelling doaj.art-b54597ac4251433e86ef4ad2d249e4a62022-12-22T01:58:24ZengSAGE PublishingTherapeutic Advances in Gastroenterology1756-283X2010-05-01310.1177/1756283X10366368Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspectiveMatt ShaleMarkus CzubGilaad G. KaplanRemo PanaccioneSubrata GhoshThe association of opportunistic infections in the context of anti-tumor necrosis factor (TNF) antibody therapies have attracted widespread attention. The recent H1N1 influenza pandemic brought this into sharp focus with numerous patient queries and physician anxieties. The following short review gives a scientific perspective to this issue including the role of vaccination.https://doi.org/10.1177/1756283X10366368
spellingShingle Matt Shale
Markus Czub
Gilaad G. Kaplan
Remo Panaccione
Subrata Ghosh
Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective
Therapeutic Advances in Gastroenterology
title Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective
title_full Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective
title_fullStr Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective
title_full_unstemmed Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective
title_short Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective
title_sort review anti tumor necrosis factor therapy and influenza keeping it in perspective
url https://doi.org/10.1177/1756283X10366368
work_keys_str_mv AT mattshale reviewantitumornecrosisfactortherapyandinfluenzakeepingitinperspective
AT markusczub reviewantitumornecrosisfactortherapyandinfluenzakeepingitinperspective
AT gilaadgkaplan reviewantitumornecrosisfactortherapyandinfluenzakeepingitinperspective
AT remopanaccione reviewantitumornecrosisfactortherapyandinfluenzakeepingitinperspective
AT subrataghosh reviewantitumornecrosisfactortherapyandinfluenzakeepingitinperspective